Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare progression-free survival (PFS) between tivozanib in combination with mFOLFOX6 with bevacizumab in combination with mFOLFOX6 based on investigator radiological tumor assessment.
Inclusion criteria
- Metastatic colorectal cancer (CRC)